MedTrace Logo

LE as a Marker for Periprosthetic Joint Infection

NCT05440032 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-01-30

No results posted yet for this study

Summary

Testing and comparison of a novel point-of-care electrochemical assay to detect and help diagnose periprosthetic joint infection on the hip and knee to the standard of care test

Conditions

  • Prosthetic-joint Infection

Interventions

DIAGNOSTIC_TEST

Semi-quantitative electrochemical leukocyte esterse test strip

Electrochemical assay to detect level of leukocyte esterase in sample

DIAGNOSTIC_TEST

Roche Chemstrip

Urinalysis chemstrip

Sponsors & Collaborators

  • Center for Innovation and Research Organization

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-07
Primary Completion
2024-03-31
Completion
2024-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440032 on ClinicalTrials.gov